Skip to main content
. 2024 Apr 15;14:1362555. doi: 10.3389/fonc.2024.1362555

Figure 3.

Figure 3

SonoVue contrast-enhanced ultrasound. (A) Hyper-enhancement of the mass in the early arterial phase at 13 seconds; (B) localized washout at 18 seconds; (C) hypo-enhancement area of the mass increased at 1 min and 40 seconds; (D) significant washout showed approximately no enhancement at 2 min and 54 seconds; (E) iso-enhancement of the abdominal lymph nodes at 1 min and 7 seconds; (F) hypo-enhancement of the left mid-abdominal mass at 1 min and 52 seconds.